ABSTRACT
Objective To detect the expressions of epidermal growth factor-like domain 7 (EGFL7) and P185 protein in breast cancer tissues and serum,and to analyze the correlation between the expression levels of EGFL7 and P185 in tissues and clinicopathological parameters of breast cancer patients. Methods Sixty patients with breast cancer in Hunan Cancer Hospital from March 2016 to March 2018 were collected as observation group,and 60 patients with breast benign lesions in the hospital during the same period were selec-ted as control group. The expressions of EGFL7 and P185 protein in tissues of patients in the two groups were detected by immunohistochemical two-step method,and the levels of EGFL7 and P185 protein in serum of patients in the two groups were detected by enzyme-linked immunosorbent assay (ELISA). The relationships between the expressions of EGFL7 and P185 protein and clinicopathological parameters of breast cancer patients were analyzed. Results The positive rates of EGFL7 in tissues in the observation group and the control group were 65. 00％ (39 / 60)and 28. 33％ (17 / 60),and there was a significant difference between the two groups (χ2 = 16. 205,P < 0. 001). The positive rates of P185 in tissues in the two groups were 43. 33％ (26 / 60)and 15. 00％ (9 / 60),and there was a significant difference between the two groups (χ2 = 11. 657,P = 0. 001). The serum levels of EGFL7 protein in the observation group and the control group were (3. 39 ± 0. 38)μg/ ml and (2. 75 ± 0. 31)μg/ ml respectively,with a significant difference (t = 10. 109,P < 0. 001). The serum levels of P185 protein in the two groups were (7. 12 ± 0. 75)μg/ ml and (6. 08 ± 0. 62)μg/ ml respectively, with a significant difference (t = 8. 279,P < 0. 001). The positive expression of EGFL7 protein was closely related to tumor size (χ2 = 6. 128,P = 0. 013),TNM stage (χ2 = 7. 781,P = 0. 005)and metastasis (χ2 =5. 444,P = 0. 020). The positive expression of P185 protein was closely related to tumor size (χ2 = 8. 910, P = 0. 003)and TNM stage (χ2 = 8. 024,P = 0. 005). Conclusion The levels of EGFL7 and P185 protein are high in breast cancer tissues and serum,and their positive expressions are related to tumor size and TNM stage. EGFL7 and P185 proteins play important roles in the progression of breast cancer.
ABSTRACT
Objective@#To detect the expressions of epidermal growth factor-like domain 7 (EGFL7) and P185 protein in breast cancer tissues and serum, and to analyze the correlation between the expression levels of EGFL7 and P185 in tissues and clinicopathological parameters of breast cancer patients.@*Methods@#Sixty patients with breast cancer in Hunan Cancer Hospital from March 2016 to March 2018 were collected as observation group, and 60 patients with breast benign lesions in the hospital during the same period were selec-ted as control group. The expressions of EGFL7 and P185 protein in tissues of patients in the two groups were detected by immunohistochemical two-step method, and the levels of EGFL7 and P185 protein in serum of patients in the two groups were detected by enzyme-linked immunosorbent assay (ELISA). The relationships between the expressions of EGFL7 and P185 protein and clinicopathological parameters of breast cancer patients were analyzed.@*Results@#The positive rates of EGFL7 in tissues in the observation group and the control group were 65.00% (39/60) and 28.33% (17/60), and there was a significant difference between the two groups (χ2=16.205, P<0.001). The positive rates of P185 in tissues in the two groups were 43.33% (26/60) and 15.00% (9/60), and there was a significant difference between the two groups (χ2=11.657, P=0.001). The serum levels of EGFL7 protein in the observation group and the control group were (3.39±0.38) μg/ml and (2.75±0.31) μg/ml respectively, with a significant difference (t=10.109, P<0.001). The serum levels of P185 protein in the two groups were (7.12±0.75) μg/ml and (6.08±0.62) μg/ml respectively, with a significant difference (t=8.279, P<0.001). The positive expression of EGFL7 protein was closely related to tumor size (χ2=6.128, P=0.013), TNM stage (χ2=7.781, P=0.005) and metastasis (χ2=5.444, P=0.020). The positive expression of P185 protein was closely related to tumor size (χ2=8.910, P=0.003) and TNM stage (χ2=8.024, P=0.005).@*Conclusion@#The levels of EGFL7 and P185 protein are high in breast cancer tissues and serum, and their positive expressions are related to tumor size and TNM stage. EGFL7 and P185 proteins play important roles in the progression of breast cancer.
ABSTRACT
OBJECTIVE@#To treat superficial hemangioma in children according to the local blood flow.@*METHODS@#A total of 98 children with superficial hemangiomas admitted to our hospital from January 2005 to June 2009, and their clinical data were analyzed.@*RESULTS@#According to the local blood flow velocity, 98 children were treated with injections or injection plus surgical treatment, respectively. Ninety-four children (95.9%) were cured.@*CONCLUSION@#Injection therapy is effective for children with superficial hemangioma, but we should arrange individualized treatment according to the local blood flow in children.